Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study

Thromb Haemost. 2008 Jan;99(1):246-8. doi: 10.1160/TH07-09-0536.
No abstract available

Publication types

  • Letter

MeSH terms

  • ABO Blood-Group System*
  • Administration, Cutaneous
  • Administration, Oral
  • Aged
  • Body Mass Index
  • Case-Control Studies
  • Estradiol / administration & dosage
  • Estradiol / adverse effects*
  • Estrogen Replacement Therapy / adverse effects*
  • Estrogens, Conjugated (USP) / administration & dosage
  • Estrogens, Conjugated (USP) / adverse effects*
  • Factor V / genetics
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Logistic Models
  • Middle Aged
  • Odds Ratio
  • Postmenopause*
  • Risk Assessment
  • Risk Factors
  • Varicose Veins / complications
  • Venous Thromboembolism / blood
  • Venous Thromboembolism / chemically induced
  • Venous Thromboembolism / etiology*
  • Venous Thromboembolism / genetics

Substances

  • ABO Blood-Group System
  • Estrogens, Conjugated (USP)
  • factor V Leiden
  • Estradiol
  • Factor V